Neko Health raised €614M in a Series C round in Jul 2026. The company is based in Stockholm, Sweden. Investors in the round: Atomico, BDT & MSD Partners, General Catalyst and 5 others. Data as of 15 Jul 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
